Mark Zetin

1.3k total citations
33 papers, 706 citations indexed

About

Mark Zetin is a scholar working on Psychiatry and Mental health, Pharmacology and Clinical Psychology. According to data from OpenAlex, Mark Zetin has authored 33 papers receiving a total of 706 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Psychiatry and Mental health, 11 papers in Pharmacology and 6 papers in Clinical Psychology. Recurrent topics in Mark Zetin's work include Treatment of Major Depression (9 papers), Electroconvulsive Therapy Studies (5 papers) and Bipolar Disorder and Treatment (5 papers). Mark Zetin is often cited by papers focused on Treatment of Major Depression (9 papers), Electroconvulsive Therapy Studies (5 papers) and Bipolar Disorder and Treatment (5 papers). Mark Zetin collaborates with scholars based in United States. Mark Zetin's co-authors include Steven G. Potkin, Larry R. Squire, Daniel F. Kripke, Joseph C. Wu, Sarah S. Mosko, Jon F. Sassin, Erin A. Hazlett, Monte S. Buchsbaum, Nancy L. Sicotte and Leighton Y. Huey and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and The Journal of Nervous and Mental Disease.

In The Last Decade

Mark Zetin

31 papers receiving 662 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Zetin United States	14	257	213	161	109	90	33	706
F. J. J. Letemendia United Kingdom	17	384 1.5×	185 0.9×	135 0.8×	60 0.6×	167 1.9×	34	898
L. Branchey United States	18	133 0.5×	140 0.7×	123 0.8×	172 1.6×	79 0.9×	25	821
Martin Jackson Australia	12	239 0.9×	233 1.1×	284 1.8×	53 0.5×	49 0.5×	23	809
Henry W. Lahmeyer United States	13	122 0.5×	160 0.8×	253 1.6×	208 1.9×	48 0.5×	27	699
W Pöldinger Switzerland	14	248 1.0×	63 0.3×	117 0.7×	116 1.1×	134 1.5×	76	753
P Kielholz Switzerland	15	174 0.7×	85 0.4×	148 0.9×	177 1.6×	199 2.2×	92	803
Marc Ziegenbein Germany	19	305 1.2×	165 0.8×	100 0.6×	73 0.7×	70 0.8×	56	1.0k
Michael D. Chafetz United States	14	165 0.6×	93 0.4×	86 0.5×	61 0.6×	69 0.8×	34	701
Stephen Kaplita United States	9	609 2.4×	155 0.7×	198 1.2×	62 0.6×	268 3.0×	18	961
Rajan Nathan United Kingdom	15	176 0.7×	134 0.6×	142 0.9×	57 0.5×	104 1.2×	76	912

Countries citing papers authored by Mark Zetin

Since Specialization

Citations

This map shows the geographic impact of Mark Zetin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Zetin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Zetin more than expected).

Fields of papers citing papers by Mark Zetin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Zetin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Zetin. The network helps show where Mark Zetin may publish in the future.

Co-authorship network of co-authors of Mark Zetin

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Zetin. A scholar is included among the top collaborators of Mark Zetin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Zetin. Mark Zetin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zetin, Mark. (2013). A Clinician’s Guide to Monoamine Oxidase Inhibitors. Current Psychiatry Reviews. 9(4). 353–364.

Zetin, Mark, et al.. (2007). Relevance of Exclusion Criteria in Antidepressant Clinical Trials. Journal of Clinical Psychopharmacology. 27(3). 295–301. 49 indexed citations

Zetin, Mark, et al.. (2006). Rational antidepressant selection: applying evidence-based medicine to complex real-world patients.. PubMed. 39(1). 38–104. 12 indexed citations

Zetin, Mark. (2004). Psychopharmacohazardology: major hazards of the new generation of psychotherapeutic drugs. International Journal of Clinical Practice. 58(1). 58–68. 7 indexed citations

Zetin, Mark, et al.. (1994). Rational antidepressant selection.. PubMed. 20(4). 209–23. 1 indexed citations

Sandman, Curt A., et al.. (1992). Cardiovascular phase relationships to the cortical event-related potential of schizophrenic, depressed, and normal subjects. Biological Psychiatry. 32(9). 778–789. 10 indexed citations

Zetin, Mark, et al.. (1992). Obsessive-Compulsive Disorder. Psychiatric Services. 43(7). 689–699. 11 indexed citations

Mosko, Sarah S., et al.. (1989). Self-reported depressive symptomatology, mood ratings, and treatment outcome in sleep disorders patients. Journal of Clinical Psychology. 45(1). 51–60. 117 indexed citations

Buchsbaum, Monte S., et al.. (1985). Topographic EEG changes with benzodiazepine administration in generalized anxiety disorder. Biological Psychiatry. 20(8). 832–842. 81 indexed citations

10.

Zetin, Mark, et al.. (1985). Organic manic disorders. Psychosomatics. 26(5). 394–402. 47 indexed citations

11.

Ds, Janowsky, et al.. (1984). Effects of methylphenidate in adult psychiatric inpatients: a preliminary report.. PubMed. 20(1). 10–7. 6 indexed citations

12.

Zetin, Mark, et al.. (1983). A simple mathematical model for predicting lithium dose requirement.. PubMed. 44(4). 144–5. 24 indexed citations

13.

Zetin, Mark, et al.. (1983). Tolerance to amoxapine antidepressant effects.. PubMed. 5(6). 638–43. 7 indexed citations

14.

Zetin, Mark & James T. Dietch. (1983). Diagnosis and Treating the Depressed Hemodialysis Patient. The International Journal of Artificial Organs. 6(3). 109–112. 2 indexed citations

15.

Zetin, Mark. (1982). Combined Use of Trimipramine and Phenelzine in Depression. The Journal of Nervous and Mental Disease. 170(4). 246–247. 1 indexed citations

16.

Zetin, Mark, et al.. (1982). Amitriptyline stimulates weight gain in hemodialysis patients.. PubMed. 18(2). 79–82. 5 indexed citations

17.

Janowsky, David S., et al.. (1981). Adult psychiatric diagnosis and symptoms compatible with the hyperactive child syndrome: a retrospective study.. PubMed. 42(10). 389–94. 33 indexed citations

18.

Zetin, Mark, Haya R. Rubin, & Robert M. Rydzewski. (1981). Tricyclic antidepressant sample stability and the vacutainer effect. American Journal of Psychiatry. 138(9). 1247–1248. 4 indexed citations

19.

Zetin, Mark, et al.. (1980). Effects of zinc in chronic hemodialysis.. PubMed. 13(1). 20–5. 18 indexed citations

20.

Huey, Leighton Y., et al.. (1978). Adult minimal brain dysfunction and schizophrenia: a case report. American Journal of Psychiatry. 135(12). 1563–1565. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact